Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Biologicals for the Treatment of Allergic Diseases and Asthma
Hern‐Tze Tina Tan, Kazunari Sugita, Cezmi A. Akdiş
Current Allergy and Asthma Reports (2016) Vol. 16, Iss. 10
Closed Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

Dupilumab for Atopic Dermatitis—From Clinical Trials to Molecular and Cellular Mechanisms
Beatriz Cabanillas
Dermatitis (2023) Vol. 34, Iss. 1, pp. 21-28
Closed Access | Times Cited: 7
Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease
John Knight, Pijus K. Mandal, Pietro Morlacchi, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 26, pp. 10026-10040
Open Access | Times Cited: 23
Histone deacetylase 11 inhibits interleukin 10 in B cells of subjects with allergic rhinitis
Jianbo Shao, Xiang‐Qian Luo, Yongjin Wu, et al.
International Forum of Allergy & Rhinology (2018) Vol. 8, Iss. 11, pp. 1274-1283
Closed Access | Times Cited: 22
A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments against Allergic Rhinitis
Bhupendra Kumar, Rohitas Deshmukh
Current Pharmaceutical Design (2024) Vol. 30, Iss. 12, pp. 887-901
Closed Access | Times Cited: 2
SGLT2 Inhibitors Empagliflozin and Canagliflozin Ameliorate Allergic Asthma Responses in Mice
Y.-A. Lee, Dong‐Soon Im
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7567-7567
Open Access | Times Cited: 2
Network pharmacology-based study of the protective mechanism of conciliatory anti-allergic decoction on asthma
Xiaobo Xuan, Ziyan Sun, Chen-Huan Yu, et al.
Allergologia et Immunopathologia (2020) Vol. 48, Iss. 5, pp. 441-449
Closed Access | Times Cited: 16
Association of IL-13 rs20541 and rs1295686 variants with symptomatic asthma in a Saudi Arabian population
Rabih Halwani, Alejandro Vazquez‐Tello, Rosan Kenana, et al.
Journal of Asthma (2017) Vol. 55, Iss. 11, pp. 1157-1165
Closed Access | Times Cited: 17
<p>Urinary Metabolomic Profiling Reveals Biological Pathways and Predictive Signatures Associated with Childhood Asthma</p>
Shuxian Li, Jinling Liu, Junfen Zhou, et al.
Journal of Asthma and Allergy (2020) Vol. Volume 13, pp. 713-724
Open Access | Times Cited: 15
Advances and Evolving Concepts in Allergic Asthma
Hui-Ying Tung, Evan Li, Cameron Landers, et al.
Seminars in Respiratory and Critical Care Medicine (2018) Vol. 39, Iss. 01, pp. 064-081
Closed Access | Times Cited: 16
Autism genes and the leukocyte transcriptome in autistic toddlers relate to pathogen interactomes, infection and the immune system. A role for excess neurotrophic sAPPα and reduced antimicrobial Aβ
Christopher Carter
Neurochemistry International (2019) Vol. 126, pp. 36-58
Closed Access | Times Cited: 14
The role of innate lymphoid cells in airway inflammation
Inge Kortekaas Krohn, Suzanne M. Bal, Korneliusz Golebski
Current Opinion in Pulmonary Medicine (2017) Vol. 24, Iss. 1, pp. 11-17
Closed Access | Times Cited: 11
Targetable pathogenic mechanisms in nasal polyposis
Alexander L. Schneider, Robert P. Schleimer, Bruce K. Tan
International Forum of Allergy & Rhinology (2021) Vol. 11, Iss. 8, pp. 1220-1234
Open Access | Times Cited: 10
ASP7266, a Novel Antibody against Human Thymic Stromal Lymphopoietin Receptor for the Treatment of Allergic Diseases
Mako Numazaki, Masaki Abe, Kaori Hanaoka, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 380, Iss. 1, pp. 26-33
Open Access | Times Cited: 10
dNP2-ctCTLA-4 inhibits German cockroach extract-induced allergic airway inflammation and hyper-responsiveness via inhibition of Th2 responses
Sangho Lim, Jung Ho Sohn, Ja‐Hyun Koo, et al.
Experimental & Molecular Medicine (2017) Vol. 49, Iss. 8, pp. e362-e362
Open Access | Times Cited: 8
Tiotropium in asthma: back to the future of anticholinergic treatment
Matteo Bonini, Nicola Scichilone
Clinical and Molecular Allergy (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Descurainia sophia Ameliorates Eosinophil Infiltration and Airway Hyperresponsiveness by Reducing Th2 Cytokine Production in Asthmatic Mice
Nai‐Chun Ting, Wen‐Chung Huang, Li‐Chen Chen, et al.
The American Journal of Chinese Medicine (2019) Vol. 47, Iss. 07, pp. 1507-1522
Closed Access | Times Cited: 7
Pharmacokinetic drug evaluation of mepolizumab for the treatment of severe asthma associated with persistent eosinophilic inflammation in adults
Lakshmi Kallur, Alexei Gonzalez‐Estrada, Frank Eidelman, et al.
Expert Opinion on Drug Metabolism & Toxicology (2017) Vol. 13, Iss. 12, pp. 1275-1280
Closed Access | Times Cited: 6
Innate Immune Mechanisms in Contact Dermatitis
Stefan F. Martin, Philipp R. Esser
Handbook of experimental pharmacology (2021), pp. 297-310
Closed Access | Times Cited: 6
Key Points for Moving the Endotypes Field Forward
Kazunari Sugita, Milena Sokołowska, Cezmi A. Akdiş
Elsevier eBooks (2018), pp. 107-114
Closed Access | Times Cited: 5
Mesenchymal Stem Cells in Asthma
Tunç Akkoç
Advances in experimental medicine and biology (2019), pp. 101-108
Closed Access | Times Cited: 5
Correlation between serum thymus and activation‐regulated chemokine levels and eczematous drug eruption following oral challenge test with clonazepam
Akio Yoshida, Kazunari Sugita, Naomi Tani, et al.
Clinical and Experimental Dermatology (2020) Vol. 45, Iss. 8, pp. 1063-1065
Closed Access | Times Cited: 4
Antibodies to Der p 1 and Der p 2 in allergic patients
Renata Harumi Cruz, Leandro Hideki Ynoue, Carolina Sánchez Aranda, et al.
Allergologia et Immunopathologia (2021) Vol. 49, Iss. 2, pp. 46-52
Open Access | Times Cited: 4
Dupilumab for Atopic Dermatitis—From Clinical Trials to Molecular and Cellular Mechanisms
Beatriz Cabanillas
Dermatitis (2022) Vol. Publish Ahead of Print
Closed Access | Times Cited: 3
Innovative Therapies for Severe Asthma.
Maj Anna Christensen, Michael Ott
PubMed (2017) Vol. 34, Iss. 12, pp. 25-31
Closed Access | Times Cited: 3
Effects of Thymus quinquecostatus Celakovski on Allergic Responses in OVA-Induced Allergic Rhinitis Mice
Sa-Haeng Kang, Dong‐Gu Kim, Dong-Keun Kim, et al.
Applied Sciences (2023) Vol. 13, Iss. 22, pp. 12449-12449
Open Access | Times Cited: 1

Scroll to top